Literature DB >> 11376470

A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia.

D Aarsland1, C Ballard, J P Larsen, I McKeith.   

Abstract

OBJECTIVES: To compare the frequency and clinical correlates of neuropsychiatric symptoms in patients with Parkinson's disease (PD) with and without dementia and in those with dementia with Lewy bodies (DLB).
METHODS: Neuropsychiatric symptoms during the month prior to assessment were assessed in clinically diagnosed PD patients with dementia (PDD; n = 48) and without dementia (PDND; n = 83) and in 98 DLB patients (33% autopsy confirmed) using standardized instruments.
RESULTS: Delusions and hallucinations were significantly more common in DLB (57% and 76%) than PDD (29% and 54%) and PDND (7% and 14%) patients (p < 0.001). In all groups, auditory and visual hallucinations and paranoid and phantom boarder delusions were the most common psychotic symptoms. Frequency of major depression and less than major depression did not differ significantly between the three groups. Clinical correlates of hallucinations in PD were dementia (odds ratio (OR) = 3.9; 95% confidence interval (CI) 1.5-10.4) and Hoehn-Yahr stage 3 or more (OR 3.4; 95% CI 1.0-12.0), whereas no significant clinical correlates of hallucinations were found in DLB patients.
CONCLUSIONS: Delusions and hallucinations occur with increasing frequency in PDND, PDD and DLB patients, but the presentation of these symptoms is similar. These findings support the hypothesis that psychiatric symptoms are associated with cortical Lewy bodies or cholinergic deficits in the two disorders. Copyright 2001 John Wiley & Sons, Ltd

Entities:  

Mesh:

Year:  2001        PMID: 11376470     DOI: 10.1002/gps.389

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  64 in total

Review 1.  Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.

Authors:  Marc R Bothe; Ingo Uttner; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2010-01-30       Impact factor: 3.575

2.  Quetiapine in the treatment of psychosis in Parkinson's disease.

Authors:  Paul Shotbolt; Mike Samuel; Anthony David
Journal:  Ther Adv Neurol Disord       Date:  2010-11       Impact factor: 6.570

Review 3.  Psychotic symptoms in Parkinson's disease. From description to etiology.

Authors:  Spiridon Papapetropoulos; D C Mash
Journal:  J Neurol       Date:  2005-07       Impact factor: 4.849

Review 4.  Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

Authors:  Daniel Weintraub; Howard I Hurtig
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

5.  [Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor].

Authors:  M Omerovic; S J Teipel; T Hampel
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

6.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

Review 7.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 9.  Current Understanding of Psychosis in Parkinson's Disease.

Authors:  Oluwadamilola O Ojo; Hubert H Fernandez
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

10.  Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.

Authors:  D Aarsland; I Litvan; D Salmon; D Galasko; T Wentzel-Larsen; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.